HomeARX • ASX
add
Aroa Biosurgery Ltd
Previous close
$0.78
Day range
$0.75 - $0.80
Year range
$0.44 - $0.82
Market cap
260.40M AUD
Avg Volume
436.22K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (NZD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 19.58M | 22.86% |
Operating expense | 19.45M | 19.70% |
Net income | -1.65M | 47.76% |
Net profit margin | -8.41 | 57.50% |
Earnings per share | — | — |
EBITDA | -1.62M | 19.59% |
Effective tax rate | -13.39% | — |
Balance Sheet
Total assets
Total liabilities
| (NZD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.90M | -37.35% |
Total assets | 105.68M | -6.12% |
Total liabilities | 13.64M | -11.64% |
Total equity | 92.05M | — |
Shares outstanding | 344.90M | — |
Price to book | 2.89 | — |
Return on assets | -5.83% | — |
Return on capital | -6.22% | — |
Cash Flow
Net change in cash
| (NZD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.65M | 47.76% |
Cash from operations | -2.43M | 33.31% |
Cash from investing | 3.90M | 303.15% |
Cash from financing | -360.50K | -29.68% |
Net change in cash | 1.04M | 137.21% |
Free cash flow | -2.23M | 25.95% |
About
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward.
The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Founded
2008
Website
Employees
261
